Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Brody

Showing results (71-80 of 170) with videos related to

Pageof 17
Sort By:
Annals of Surgery|July 5, 2021
The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery ClinicTheresa P Yeo, Ryan W Fogg, Ayako Shimada, et al.
Cell Cycle (Georgetown, Tex.)|May 19, 2009
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survivalJonathan R Brody, Christina L Costantino, Adam C Berger, et al.
Cancer|November 17, 2011
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinomaMatias E Valsecchi, Mary McDonald, Jonathan R Brody, et al.
The American Journal of Pathology|May 5, 2009
An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancersAgnieszka K Witkiewicz, Abhijit Dasgupta, Federica Sotgia, et al.
Cancer Biology & Therapy|July 21, 2006
A proposed clinical test for monitoring fluoropyrimidine therapy: detection and stability of thymidylate synthase ternary complexesJonathan R Brody, Eike Gallmeier, Kiyoshi Yoshimura, et al.
Cell Cycle (Georgetown, Tex.)|April 28, 2011
Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancersAgnieszka K Witkiewicz, Jessica Kline, Maria Queenan, et al.
Journal of Pancreatic Cancer|February 22, 2019
Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple ProcedureTyler M Bauer, Teena Dhir, Adam Strickland, et al.
Oncotarget|July 10, 2015
Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancerAgnieszka K Witkiewicz, Nicholas A Borja, Jorge Franco, et al.
JCO Precision Oncology|September 21, 2018
Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer TypesArielle L Heeke, Michael J Pishvaian, Filipa Lynce, et al.
The American Journal of Pathology|July 28, 2004
Functional defects in the fanconi anemia pathway in pancreatic cancer cellsMichiel S van der Heijden, Jonathan R Brody, Eike Gallmeier, et al.
Pageof 17

Showing results (71-80 of 170) with videos related to

Sort By:
Pageof 17
Annals of Surgery|July 5, 2021
The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery ClinicTheresa P Yeo, Ryan W Fogg, Ayako Shimada, et al.
Cell Cycle (Georgetown, Tex.)|May 19, 2009
Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survivalJonathan R Brody, Christina L Costantino, Adam C Berger, et al.
Cancer|November 17, 2011
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinomaMatias E Valsecchi, Mary McDonald, Jonathan R Brody, et al.
The American Journal of Pathology|May 5, 2009
An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancersAgnieszka K Witkiewicz, Abhijit Dasgupta, Federica Sotgia, et al.
Cancer Biology & Therapy|July 21, 2006
A proposed clinical test for monitoring fluoropyrimidine therapy: detection and stability of thymidylate synthase ternary complexesJonathan R Brody, Eike Gallmeier, Kiyoshi Yoshimura, et al.
Cell Cycle (Georgetown, Tex.)|April 28, 2011
Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancersAgnieszka K Witkiewicz, Jessica Kline, Maria Queenan, et al.
Journal of Pancreatic Cancer|February 22, 2019
Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple ProcedureTyler M Bauer, Teena Dhir, Adam Strickland, et al.
Oncotarget|July 10, 2015
Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancerAgnieszka K Witkiewicz, Nicholas A Borja, Jorge Franco, et al.
JCO Precision Oncology|September 21, 2018
Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer TypesArielle L Heeke, Michael J Pishvaian, Filipa Lynce, et al.
The American Journal of Pathology|July 28, 2004
Functional defects in the fanconi anemia pathway in pancreatic cancer cellsMichiel S van der Heijden, Jonathan R Brody, Eike Gallmeier, et al.
Pageof 17